Healthcare Market Research Reports & Industry Analysis
MarketResearch.com provides detailed reports for various countries around the world and the healthcare needs and offerings in those countries. These reports also profile the types of administrations and regulations and policies that are in place in various regions and segments in each country.
Reports are available in industry sub-categories such as: wellness and preventative programming, sports medicine, insurance and managed care, and clinical guidelines and best practices. Readers may also find data regarding alternative and complementary medicine, nursing, public health and information technology. Though not always considered when first thinking of healthcare, information may also be found on veterinary health.
Reviews of various equipment and pharmaceuticals in specific regions are made available regarding multiple countries. Herbal and traditional products are contrasted and compared, and global access to sufficient ambulance services is discussed.
Healthcare Industry Research & Market Reports
-
Nicaragua Pharmaceuticals & Healthcare Q3 2018
... has seen attacks on health facilities and their staff across the nation, will provide headwinds for stakeholders inthe country in 2018. Nevertheless, we retain our view that the market will report strong performance from 2019 ... Read More
-
Laos Pharmaceuticals & Healthcare Q3 2018
... to act as key drivers of market growth. Meanwhile, the government will remain committed to improving the regulatoryand business environment. That said, the small domestic drug market, combined with low spending per capita on medicine ... Read More
-
Azerbaijan Pharmaceuticals & Healthcare Q3 2018
... impact on the healthcare andpharmaceutical opportunities in the country. Increased public sector funding should significantly reduce the over-reliance on out-of-pocket payments, footed by the, generally speaking, low-income population. The country's demographic profile also doesprovide commercial ... Read More
-
Austria Pharmaceuticals & Healthcare Q3 2018
... incomparison to its EU partners. However, like its eurozone neighbours, we believe Austria's pharmaceutical spending will be subduedover the medium term, as states scramble to contain rising pharmaceutical expenditure in line with increasing healthcare demands. Read More
-
Botswana Pharmaceuticals & Healthcare Q3 2018
... by a weakregulatory environment, small pensionable population and a highly ruralised community. Generic medicines will continue todominate the market, with patented drugmakers choosing to operate in larger markets in the region such as South African. Read More
-
Hungary Pharmaceuticals & Healthcare Q3 2018
... its regional peers in the coming years. Whilean ageing population will support long-term market growth, significant healthcare funding issues remain prominent, leading tomedicine shortages and growing waiting lists, while also placing pressure on pharmaceutical expenditure. Read More
-
Gabon Pharmaceuticals & Healthcare Q3 2018
... diseases will remain significant, we expect the increasein the incidence of non-communicable diseases to be the key driver of longer-term pharmaceutical market's trajectory. Commercialopportunities will mostly remain in the generic segment, given the rising role ... Read More
-
Costa Rica Pharmaceuticals & Healthcare Q3 2018
... and development opportunities tomultinationals, based on factors such as continuous improvement in healthcare infrastructure and government commitment toupholding an attractive business environment. Additionally, the demand for innovative medicines will still need to be met through ... Read More
-
Mental Health & Substance Abuse Services
... include Acadia Healthcare, Hazelden Betty Ford Foundation, and Spectrum Health Systems (all based in the US), along with the Centre for Addiction and Mental Health (Canada), and the Crossroads Centre (Antigua). COMPETITIVE LANDSCAPE Demand for ... Read More
-
Marijuana Stores
... The multibillion-dollar global industry is experiencing strong growth, though the newness of the market and variance in regulation across geographies creates major barriers to entry. The industry includes medical marijuana dispensaries and stores that sell ... Read More
-
Health Insurance Carriers
... and UnitedHealth Group (all based in the US), as well as AEGON (the Netherlands), Allianz (Germany), and BUPA (UK). COMPETITIVE LANDSCAPE Demand for health insurance products is driven by cost of medical care. The profitability ... Read More
-
Brookdale Senior Living Inc (BKD) - Financial and Strategic SWOT Analysis Review
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ... Read More
-
Henry Ford Health System - Strategic SWOT Analysis Review
... company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. ... Read More
-
Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Allina Health - Strategic SWOT Analysis Review
... employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business ... Read More
-
Panama Pharmaceuticals & Healthcare Q3 2018
... market, Panama will continue to attract interestfrom foreign pharmaceutical companies, reinforcing its role as a re-export hub of pharmaceuticals to the Latin American region.Although Panama's economic growth and, therefore, healthcare spending headlines will remain vulnerable ... Read More
-
Philippines Pharmaceuticals & Healthcare Q3 2018
... disease profile will continue to evolve in line with economic anddemographic trends and will provide a number of revenue earning opportunities for pharmaceutical firms, a multitude of regulatoryissues will create challenges while policies implemented to ... Read More
-
Jordan Pharmaceuticals & Healthcare Q3 2018
... diseases among the population. Meanwhile, we expectthe government to maintain a positive business environment for the pharmaceutical industry due to its strategic importance toJordan's economy, ensuring that the country remains a net exporter of medicines. Read More
-
Qatar Pharmaceuticals & Healthcare Q3 2018
... government’s commitment towards promoting the developmentof the healthcare sector will support this trend. While local drug manufacturing capacity will continue to increase, Qatar will remaindependent on pharmaceutical imports over the foreseeable future. Despite the favourable ... Read More
-
Asia Pharmaceuticals & Healthcare Q3 2018
... the smaller, underdeveloped pharmaceutical markets willpresent the weakest commercial incentives owing to their relative market size and level of pharmaceutical development. Highergrowth opportunities in the smaller emerging markets will present themselves within the generic medicines ... Read More
-
Europe Pharmaceuticals & Healthcare Q3 2018
... to region-specific trends. Themore developed Western markets will continue to be favoured by innovative drugmakers due to stronger regulatory oversight andgreater purchasing power, although growth in these markets will be suppressed by aggressive cost-containment. Revenue ... Read More
-
Sub-Saharan Africa Pharmaceuticals & Healthcare Q3 2018
... procedures, a lack of enforced patent laws, and ageneral lack of transparency that ensures the region lags behind others globally for revenue-earning opportunities. Despite this, theregion's pharmaceutical markets will continue to provide long-term opportunities for ... Read More
-
Spain Pharmaceuticals & Healthcare Q3 2018
... Spain’s out-of-pocket expenditure onhealth is well above the EU average, a result of health reforms which shifted some of the costs for healthcare and medicine ontohouseholds. These trends, combined with the forecasted economic slowdown in ... Read More
-
Russia Pharmaceuticals & Healthcare Q3 2018
... policy continuity will lead toincreased investment in localised drug production in the market, although this will remain heavily weighted towards the genericmedicines sector given the continued regulatory issues and market access barriers for innovative drugmakers. Read More
-
Tunisia Pharmaceuticals & Healthcare Q3 2018
... expect it to retain this position over the long term. Highlighting themarket's longer-term potential, some multinational drugmakers have shown their willingness to do business in the country, thoughthe majority choose to operate indirectly to minimise ... Read More
